Overactive Bladder With Urgency, Frequency, And Incontinence Therapeutics
1. Vesicare patent expiration
Treatment: NA
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6017927 | ASTELLAS | Quinuclidine derivatives and medicinal composition thereof |
Nov, 2018
(7 years ago) | |
|
US6017927 (Pediatric) | ASTELLAS | Quinuclidine derivatives and medicinal composition thereof |
May, 2019
(6 years ago) | |
Drugs and Companies using SOLIFENACIN SUCCINATE ingredient
Market Authorisation Date: 19 November, 2004
Dosage: TABLET
How can I launch a generic of VESICARE before it's drug patent expiration?
More Information on Dosage
VESICARE family patents
